print

Business partners section   

Welcome to the section for business partners.  Here, you will find information concerning various cooperation opportunities, active pharmaceutical ingredients, and finished dosage forms manufactured by Polpharma and research conducted by the Company.

 
Polpharma is the largest manufacturer of drugs and active pharmaceutical ingredients (APIs) in Poland. Our extensive portfolio creates possibilities for competing in various areas of the market. POLPHARMA’s products are exported to over 50 countries of the world.
 

Finished dosage forms

In one of the largest and most modern pharmaceutical factories in Europe, the Company manufactures solid forms of drugs, such as tablets, coated and film-coated tablets, effervescent tablets, and hard capsules. The production capacity for solid forms is 6 billion units per year. Full hermetization allows for the protection of drugs against any possible contaminants, as well as the protection of employees against contact with chemical substances.
 

Active pharmaceutical ingredients

The total capacity of the company reactors is 320,000 liters. The facilities for manufacturing APIs are subject to regular FDA inspections. Installations for the production of substances and finished dosage forms have GMP certificates issued by the General Pharmaceutical Inspectorate and PIC/S (Pharmaceutical Inspection Cooperation Scheme).
 

Business development

Besides for manufacturing for its own purposes, the Company provides contract production services with regard to the manufacture of APIs, solid forms and liquid forms of drugs. We also offer registration documentation for finished dosage forms manufactured based on own pharmaceutical APIs, as well as substances acquired from external suppliers. Documentation is prepared in the CTD format compliant with the EU requirements.
 

Environmental protection and safety at work

Polpharma implemented the Integrated Environmental and OSH Management System. As evidence that it meets the international standards in that respect, the company was awarded the ISO 14001 and OHSAS 18001/PN-N-18001 certificates as issued by Det Norske Veritas (DNV).

Polpharma Group:

Strategic partner:

© POLPHARMA S.A. All rights reserved.
Realizacja: Ideo